The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer
Authors
Keywords
-
Journal
CANCER LETTERS
Volume 556, Issue -, Pages 216064
Publisher
Elsevier BV
Online
2023-01-14
DOI
10.1016/j.canlet.2023.216064
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The PI3K/AKT/mTOR signaling pathway inhibitors enhance radiosensitivity in cancer cell lines
- (2021) Alireza Mardanshahi et al. MOLECULAR BIOLOGY REPORTS
- Sirt4: A Multifaceted Enzyme at the Crossroads of Mitochondrial Metabolism and Cancer
- (2020) Daniela Tomaselli et al. Frontiers in Oncology
- Oxidative Stress in Cancer
- (2020) John D. Hayes et al. CANCER CELL
- Glutamic-Pyruvic Transaminase 1 Facilitates Alternative Fuels for Hepatocellular Carcinoma Growth—A Small Molecule Inhibitor, Berberine
- (2020) Wei Guo et al. Cancers
- 5-fluorouracil enhances the anti-tumor activity of the glutaminase inhibitor CB-839 against PIK3CA-mutant colorectal cancers
- (2020) Yiqing Zhao et al. CANCER RESEARCH
- Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck
- (2020) D. Day et al. ORAL ONCOLOGY
- Abrogating GPT2 in triple‐negative breast cancer inhibits tumor growth and promotes autophagy
- (2020) Devina Mitra et al. INTERNATIONAL JOURNAL OF CANCER
- Mammalian Target of Rapamycin 2 (MTOR2) and C-MYC Modulate Glucosamine-6-Phosphate Synthesis in Glioblastoma (GBM) Cells Through Glutamine: Fructose-6-Phosphate Aminotransferase 1 (GFAT1)
- (2019) Bo Liu et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome
- (2019) Suzy Scholl et al. EBioMedicine
- Glutamine Synthetase Promotes Radiation Resistance via Facilitating Nucleotide Metabolism and Subsequent DNA Damage Repair
- (2019) Shujun Fu et al. Cell Reports
- Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial
- (2019) Samantha Cabral S. da Costa et al. JOURNAL OF CLINICAL ONCOLOGY
- Targets for improving tumor response to radiotherapy
- (2019) Keywan Mortezaee et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A Phase Ib Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity-Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma
- (2019) Lara A. Dunn et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Targeting of β-catenin reverses radioresistance of cervical cancer with the PIK3CA E545K mutation
- (2019) Wei Jiang et al. MOLECULAR CANCER THERAPEUTICS
- The Role of Sirtuins in Antioxidant and Redox Signaling
- (2018) Chandra K. Singh et al. ANTIOXIDANTS & REDOX SIGNALING
- Phosphatidylinositol 3-Kinase α–Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study
- (2018) Dejan Juric et al. JOURNAL OF CLINICAL ONCOLOGY
- Leucine Signals to mTORC1 via Its Metabolite Acetyl-Coenzyme A
- (2018) Sung Min Son et al. Cell Metabolism
- Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer
- (2018) Hyun Ju Kim et al. GYNECOLOGIC ONCOLOGY
- The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer
- (2018) Wei Jiang et al. Journal of Hematology & Oncology
- HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma
- (2017) Wenzhu Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A phase I study of mTOR inhibitor everolimus in association with cisplatin and radiotherapy for the treatment of locally advanced cervix cancer: PHOENIX I
- (2016) Andréia Cristina de Melo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
- (2016) Yujun Hao et al. Nature Communications
- Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer
- (2015) E. Deutsch et al. ANNALS OF ONCOLOGY
- Characterization of the Novel and Specific PI3K Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials
- (2014) C. Fritsch et al. MOLECULAR CANCER THERAPEUTICS
- Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation
- (2013) Lisha Xiang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- SIRT4 Has Tumor-Suppressive Activity and Regulates the Cellular Metabolic Response to DNA Damage by Inhibiting Mitochondrial Glutamine Metabolism
- (2013) Seung Min Jeong et al. CANCER CELL
- The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4
- (2013) Alfred Csibi et al. CELL
- The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of Radiobiology
- (2013) J.S. Good et al. CLINICAL ONCOLOGY
- ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation
- (2012) Guoliang Qing et al. CANCER CELL
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- The Proteasome Activator PA200 Regulates Tumor Cell Responsiveness to Glutamine and Resistance to Ionizing Radiation
- (2012) J. Blickwedehl et al. MOLECULAR CANCER RESEARCH
- Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
- (2010) F. Weinberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Detection of the mitochondrial and catalytically active alanine aminotransferase in human tissues and plasma
- (2009) Glinghammar INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
- (2009) Ping Gao et al. NATURE
- p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc
- (2008) N Sankar et al. ONCOGENE
- Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis
- (2008) R. Brooks Robey et al. SEMINARS IN CANCER BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now